Detalhe da pesquisa
1.
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
BMC Nephrol
; 20(1): 372, 2019 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31619187
2.
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Lancet
; 386(10004): 1649-58, 2015 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26231455
3.
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Blood
; 121(3): 537-45, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169778
4.
Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study.
Am J Hematol
; 90(7): 598-601, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25801698
5.
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.
Clin J Am Soc Nephrol
; 17(9): 1325-1336, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918106
6.
Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Clin Ther
; 31(4): 764-76, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19446149
7.
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.
Lancet Haematol
; 2(8): e315-25, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26688484
8.
Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.
Hum Mol Genet
; 11(5): 515-23, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11875046